FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

RightEye Promoting Off-Label Use: FDA

FDA warns Bethesda, MD-based RightEye that it is promoting off-label use of its adulterated and misbranded RightEye Vision System.

latest-news-card-1
Human Drugs

Multiple Violations at Adept Life Science

FDA warns Chandler, AZ-based Adept Life Science about CGMP and misbranding violations in its production of dietary supplements.

latest-news-card-1
Human Drugs

GDUFA 2022 Science and Research Report

FDA issues the FY 2022 GDUFA Science and Research Report with information on projects in 13 scientific areas.

latest-news-card-1
Human Drugs

Improve Biosimilar Development and Approval Efficiency

Two FDAers introduce a journal issue exploring ways in which clinical pharmacology innovations can expand the development and approval of biosimilars.

latest-news-card-1
Human Drugs

Externally Controlled Trial Guidance

FDA publishes a draft guidance with considerations for designing and conducting externally controlled trials for drug and biological products.

latest-news-card-1
Human Drugs

FDA 'Defying' Appeals Court is Troubling: Attorneys

Two Epstein Becker attorneys say an FDA statement challenging the 11th Circuit Court of Appeals application of its position on orphan drug exclusivity...

latest-news-card-1
Biologics

CBER 2023 Guidance Agenda

FDA publishes its 2023 guidance agenda listing 11 guidances it is considering developing this year.

latest-news-card-1
FDA General

Biden Administration Ending Public Health Emergency 5/11

The Biden Administration announces that it will end the current Covid-19 public health emergency declaration and national emergency declaration, which...

latest-news-card-1
Biologics

CBER Tissues/Advanced Therapies Director Bryan Retiring

After more than 22 years at FDA, CBER Office of Tissues and Advanced Therapies director Wilson Bryan announces he is retiring in March.

latest-news-card-1
FDA General

Califf Proposes Transformation of Foods Program, ORA

FDA commissioner Robert Califf announces a new transformative vision for the agencys human foods program and the Office of Regulatory Affairs that add...